Correlation Between Cell Source and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cell Source and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cell Source and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cell Source and Processa Pharmaceuticals, you can compare the effects of market volatilities on Cell Source and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cell Source with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cell Source and Processa Pharmaceuticals.

Diversification Opportunities for Cell Source and Processa Pharmaceuticals

-0.33

Correlation Coefficient

Cell Source  Processa Pharmaceuticals

Very good diversification

The 3 months correlation between Cell and Processa is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Cell Source and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Cell Source is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cell Source are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Cell Source i.e., Cell Source and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cell Source and Processa Pharmaceuticals

Given the investment horizon of 90 days Cell Source is expected to generate 1.17 times more return on investment than Processa Pharmaceuticals. However, Cell Source is 1.17 times more volatile than Processa Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  27.00  in Cell Source on May 19, 2025 and sell it today you would earn a total of  8.00  from holding Cell Source or generate 29.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Cell Source  vs.  Processa Pharmaceuticals

Cell Source

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Cell Source are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Cell Source unveiled solid returns over the last few months and may actually be approaching a breakup point.

Processa Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cell Source and Processa Pharmaceuticals

The main advantage of trading using opposite Cell Source and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cell Source position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Cell Source and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.